EMA Biennial Report 2016/2017: Joint CVMP/CHMP Working group on the Application of the 3Rs in Regulatory Testing of Medical Products

By Anna Jurczynska | March 7, 2018

This report is aimed at informing pharmaceutical companies and the public of the EMA activities in relation to “3Rs” (replacement, reduction, refinement) during 2016 and 2017. The report summarises the recommendations developed and the organisational structure enabling the development of such guidance. It also looks into the future with details about a new mandate to…

Read More